Global Prostate Cancer Therapeutics Market to Reach US$23.23 Billion by 2030, Driven by Rising Prevalence and Advanced Hormonal Therapies
Prostate cancer, the most common non-cutaneous cancer globally, is primarily influenced by factors such as the aging population, sedentary lifestyles in industrialized countries, and the …